ArticleJournal of Cancer2019

Nab-paclitaxel plus gemcitabine as first-line treatment for advanced pancreatic cancer: a systematic review and meta-analysis.

Yiyin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.